DNAË«Á´¶ÏÁÑÐÞ¸´,DNA double-strand break (DSB) repairÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ϸ°û½Çµ°°×19(CK19),CK19 mRNAÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
3-µâÜÐëÒ,123I-metaiodobenzyl guanidineÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ëæ·Ã·ÖÎö,Subsequent SurveyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÊÖÊõÁÆÐ§·ÖÎö,Operation-effect analysisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
µ¥±Ç¿×¾µûÈë·,single nostril transsphenoidal approachÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÄÚ·ÖÃÚÀàÐÍ,endocrine typeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
e-flow¼¼Êõ,e-flow techniqeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¼××´ÏÙ΢СÈéÍ·×´°©,papillary thyroid microcarcinomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Éñ¾ÄÚ¾µÊÖÊõ,Neuroendoscopic surgeryÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
²»È«Âé±Ô,incomplete paralysisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÉàÑ×,lingual inflammationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÐØÏÙÁöÇгýÊõ,excision of thymomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
δ·Ö»¯¼××´ÏÙ°©,anaplastic thyroid cancerÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
°©Ï¸°û¼«ÐÔ,cellular polarityÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
°©Ï¸°ûÕ³¸½ÐÔ,cellular cohesivenessÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
À©´ó¾µûñ¼¼¼Êõ,Extended transsphenoidal techniqueÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¼××´ÏÙ×éÖ¯Ìæ´ú²ÄÁÏ,thyroid tissue substituteÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÄÚ·ÖÃÚÏÙÁö,endocrine neoplasiaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Õý³£¼××´ÏÙ×éÖ¯,Normal thyroid tissueÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÊõºóÉú´æµ÷²é,Prognosis AnalyzeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÐØÏÙÉÏÆ¤Ô´ÐÔÖ×Áö,Tumor of the thymic epitheliumÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
WHO²¡Àíѧ·ÖÐÍ,WHO pathological typeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¾±Çµû,transsphenoidal approachesÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÁÙ´²±íÏÖʵÑéÊÒ¼ì²é,manifestion laboratory testÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
´¹ÌåǰҶ¹¦ÄÜ,Anterior pituitary functionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
´¹ÌåºóÒ¶¹¦ÄÜ,Posterior pituitary functionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¹¦ÄÜÐÔÒȵºËØÁö,Functional insulinomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÊõÖÐѪÌǼà²â,Blood glucose monitoring in operationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
µ¥´¿ÒȵºËØÁöÕª³ýÊõ,Resection of insulinomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
±Õ¾¡«ÃÚÈé×ÛºÏÖ¢,Forhis¡«Albright syndromeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÉöÉÏÏÙÊÈËáϸ°ûÁö,Adrenocortical oncocytomasÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
»ù½ð×ÊÖúÎÄÏ×,Fund sponsored literatureÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
SPECT/CT-ÈÚºÏÏÔÏñ,~(131)¢ñ-SPECT/CT fuse imagingÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Éú³¤¼¤ËØÏÙÁö,growth hormone secreting pituitary adenomasÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
WHO×é֯ѧ·ÖÐÍ,WHO histologic classificationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¸ß¸ÆÎ£Ïó,high calcium crisisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ë®ÄÆÎÉÂÒ,metabolic disturbance of water and natriumÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ͬÐIJã×´¹¹Ôì,concentric lamellated structureÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÉöÉÏÏÙ·¦Ö¬ÖÊÐÔÖ×Áö,Adrenal lipid-poor neoplasmsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÒȵºËØÊÍ·ÅÖ¸Êý,Ratio of insulin to glucoseÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÉöÉÏÏÙ¼²²¡/Íâ¿ÆÊÖÊõ,adrenal gland diseases/surgeryÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
°°µ×,sellar floorÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÖÐÑë×éÁܰͽá×ªÒÆ,Lymph Node ResectionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÊÈËáÐÔÏÙÁö,Hurthle cell adenomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
°©½á½Ú,Cancer nodulesÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÒȵºÏ¸°ûÖ×Áö,Islet cell tumor(ICT)Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÉöÉÏÏÙÁܰÍÁö,adrenal lymphomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ѫ½¬Tgˮƽ,serum TgÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ѫ½¬TSHˮƽ,serum TSHÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Êȸõϸ°ûÁö12ϸ°û,pheochromocytoma 12 cellÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ëø¹ÇÏÂ;¾¶,Infraclavicular approachÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÒȵºÏ¸°ûÁö/Õï¶Ï,Islet Cell Tumor/diagÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÒȵºÏ¸°ûÁö/ÖÎÁÆ,Islet Cell Tumor/therÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¸ÄÁ¼ÐÔ¾±ÇåɨÊõ,Mmodified neck dissectionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¶ÙÒÖÏÖÏó,stunning phenomenonÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
´ï·ÒÆæÍâ¿ÆÏµÍ³,da Vinci Surgical SystemÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÎÞ¹¦ÄÜÐÔÒȵºÏ¸°ûÁö/ÖÎÁÆ,Non-functional Islet Cell Tumor/therÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÉöÉÏÏÙСÖ×Áö,Small adrenal tumorÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÂËÅÝÉÏÆ¤ÆðÔ´¼××´ÏÙÖ×Áö,follicular epithelium neapelsm of the thyroidÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¶àÆ½ÃæÖØ½¨¼¼Êõ,multiplannar reconstructionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
µ¥²¡ÖÖÁÙ´²Â·¾¶,Single disease clinic pathwaysÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÑÇÁÙ´²Êȸõϸ°ûÁö,subclinical pheochromocytomasÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÇÖÏ®ÐÔÓë·ÇÇÖÏ®ÐÔ,invasion and non-invasionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¹ÌÏàpHÌݶÈË«ÏòÄý½ºµçÓ¾,immobilized pH gradient two-dimensional polyacrylamide gel electrophoresisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ºó¸¹Ç»¾µÉöÉÏÏÙÇгýÊõ,posterior laparoscopic adrenalectomyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
BRAFÍ»±ä,BRAF mutationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¾µûÈë·ÊÖÊõ,Endonosal transsphenoidal surgeryÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
°°µ×ÐÞ²¹,Sellar base repairÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÒÈÏÙ¾±²¿Ö×Áö,Tumor of pancreatic neckÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÒÈÏÙÖжÎÇгý,Middle pancreatectomyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
³¬¸ßƵ²¨,Ultrahigh frequency wavesÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¼××´ÏÙÖ×ÁöÐÔ²¡±ä,Thyroid tumors diseasesÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
TÁܰÍÁöÇÖÏ®×ªÒÆ»ùÒò,T lymphoma invasion and metastasisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
fmsÑùÀÒ°±Ëἤø4,fms like tyrosine kinase 4Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Çгý·¶Î§,resection extentÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÉöÉÏÏÙ×ªÒÆÐÔÖ×Áö,metastatic adrenal tumorÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
´Ù¼××´ÏÙ¼¤ËØÒÖÖÆÁÆ·¨,Thyroid stimulating hormone inhibition therapyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¼××´ÏÙËØÌæ´úÖÎÁÆ,Thyroid hormone replacement therapyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Tat×÷Óõ°°×30,Tat interacting protein 30Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
°°ëõ,diaphragma sellae duraÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Éú³¤¼¤ËØÐÍ´¹ÌåÏÙÁö,Growth hormone(GH)-secreting pituitary adenomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¼Ì·¢Ö×Áö,secondary tumorÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¼××´ÅÔÏÙÖ¬·¾ÏÙÁö,Parathyroid lipoadenomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¶ùͯ¼××´ÏÙ°©,childhood thyroid carcinomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
µòÍöµ°°×ø»î»¯Òò×Ó,apoptotic protease activating factorÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÃâÒß×黯S-PȾɫ,S-P immunohistochemical stainingÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¼××´ÏÙÂËÅÝ×´ÏÙÁö,thyroid follicular adenomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¼××´ÏÙÖ×Áö/·ÅÉäÉãÓ°Êõ,thyroid neoplasms/radiographyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¼××´ÏÙ½á½Ú/·ÅÉäÉãÓ°Êõ,thyroid nedule/radiographyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
µ¥±Ç¿×¾µûÏÔ΢ÊÖÊõ,endonasal transsphenoidal surgeryÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
·ÖÀëÃæ»ý,Segregation areaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
·Ö»¯ÐÍ,differentiated thyroid carcinomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÄÚ¾µ±ÇÄÚ¾µûÈë·,Endoscopic endonasal transsphenoidal approachÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
»¡ÐÍСÇпÚ,Small-arc incisionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
½âÆÊÇгý,Dissective cuttingÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¼××´ÏÙ°©¸ßϸ°ûÐͱäÒì,columnar cell variantÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Öù״ϸ°ûÐͱäÒì,tall cell variantÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÃÖÂþÐÔÓ²»¯ÐÔ±äÒì,diffuse sclerosing variantÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
µâÍ¬Î»ËØ/ÖÎÁÆÓ¦ÓÃ,isotopes/therapeulic applyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«

|